MCPsych — Execution
Supports United Kingdom research on anhedonic depression to accelerate treatment development pathways.
MCPsych (Multi-Channel Psychiatry) is a $50 million Wellcome Leap program building an integrated computational and biological model of anhedonic depression — a severe subtype characterized by the inability to experience pleasure. Program Director Susanne Ahmari, MD, PhD, a psychiatrist and neuroscientist with expertise in translational research and OCD mechanisms, leads the initiative. The program…
Integrated computational and biological model of anhedonic depression spanning genes, molecules, cells, and human data to improve first-attempt treatment effectiveness and long-term survival rates.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
Find grantsGrants for Small Business Startup: Eligibility Checklist
Check whether your deeptech company is eligible for grants for small business startup funding, including SBIR/STTR, EIC Accelerator, and Innovate UK support.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
Moonshot R&D Program — Open PM and Project-Team
🇯🇵CSTI Japan · Japan
Funds disruptive Japan-wide missions in science, society, and advanced technology.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.